SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 60.74 |
| Enterprise Value ($M) | 15.55 |
| Book Value ($M) | 134.23 |
| Book Value / Share | 3.20 |
| Price / Book | 0.45 |
| NCAV ($M) | 126.78 |
| NCAV / Share | 3.03 |
| Price / NCAV | 0.48 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.42 |
| Return on Assets (ROA) | -0.31 |
| Return on Equity (ROE) | -0.35 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 15.32 |
| Current Ratio | 15.32 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 141.53 |
| Assets | 148.99 |
| Liabilities | 14.76 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BML Investment Partners, L.P. | |||
| 13G | Deep Track Capital, LP | |||
| 13G/A | Biotechnology Value Fund L P | |||
| 13G/A | Gilead Sciences Inc | |||
| 13G | Blue Owl Capital Holdings LP | 8.48 | ||
| 13G/A | Bristol Myers Squibb Co | 4.40 | 0.00 | |
| 13G/A | Fmr Llc | 2.77 | -70.96 | |
| 13G/A | Omega Fund VI, L.P. | 4.70 | 0.00 | |
| 13G/A | Citadel Advisors Llc | 0.40 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 9,443 | 81,630 | 11.57 | |
| 3,937 | 22,504 | 17.49 | |
| 8,967 | 65,007 | 13.79 | |
| 10,229 | 49,700 | 20.58 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| HCWB – HCW Biologics Inc. | HRMY – Harmony Biosciences Holdings, Inc. |
| HROW – Harrow, Inc. | IMRX – Immuneering Corporation |
| IOVA – Iovance Biotherapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io